The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Tempus AI is the larger company, worth $12.0B, about 1.5 times Hinge Health.
  • Hinge Health grew revenue faster over the last year (+53.0% vs +21.6%).
  • Hinge Health keeps more of each dollar of revenue as operating profit (13.0% vs -19.8%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureHNGETEM
Market cap$8.1B$12.0B
Share price$102.90$70.35
Revenue (last fiscal year)$588M$1.3B
Free cash flow (last fiscal year)$165M-$239M
Revenue growth, last year+53.0%+21.6%
Revenue growth per year, last 5 fiscal years+41.7%+58.3%
Operating margin13.0%-19.8%
Net margin15.2%-17.8%
Return on equity31.7%-57.2%
P/E (trailing)——
Price / free cash flow47.2x—
EV / EBITDA68.7x—
FCF growth the price implies16.7%—
Dividend yield——
Debt / equity1.40x4.32x
Fundamental gradeCF
Superinvestors holding it43
Insider purchases, last 12 months02

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Hinge Health

YearRevenueFree cash flowOp. margin
2023$293M-$69M-44.6%
2024$390M$45M-8.2%
2025$588M$165M-92.9%

Tempus AI

YearRevenueFree cash flowOp. margin
2022$321M-$187M-82.8%
2023$532M-$249M-36.9%
2024$693M-$211M-99.7%
2025$1.3B-$239M-19.9%

Where the revenue comes from

Hinge Health

No segment breakdown reported.

Tempus AI · by products, 2025

Diagnostics$955M75%
Data and applications$316M25%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open HNGE in Investingly

Questions

Which is bigger, Hinge Health or Tempus AI?

Tempus AI (TEM), at $12.0B against $8.1B.

Which grows faster, HNGE or TEM?

Hinge Health: revenue grew +53.0% over the last year, against +21.6%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.